We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
When to tell DVLA if you've had a stroke or TIA (mini-stroke), forms to fill in and send if you need to inform DVLA
Advice for medical professionals to follow when assessing drivers with neurological disorders.
This rapid literature review explores the role that media in the Western Balkans plays in issues of gender (in)equality
Information on enhancing communications resilience and how we work with telecommunication service providers to manage the risk of disruption to public networks.
How to use a cost benefit analysis to evaluate your digital health product.
Guidance on how to report a security vulnerability on any Ministry of Defence service or system, such as the websites of the Royal Air Force, British Army and Royal Navy.
The review of the safety of isotretinoin has concluded.
Foreign Secretary Lord Cameron gave his first major speech in the role at the National Cyber Security Centre.
Employment Appeal Tribunal Judgment of Mrs Justice Eady on 24 May 2024.
Population screening programmes can cause harms as well as benefits, which need to be weighed up by the UK National Screening Committee (UK NSC).
Guidance for inspecting engineers including the reporting of section 10 inspection findings.
Looking into what can lead to people making mistakes and how to mitigate errors.
Globally, there has been a very small number of reports of new-onset or aggravation of pre-existing myasthenia gravis with atorvastatin, pravastatin, lovastatin, fluvastatin, simvastatin, rosuvastatin and pitavastatin (single-ingredient and fixed-dose combination products). Advise patients taking statins to be alert to...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).